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The  thymus  is  the  site  of  considerable  cell  proliferation  and  turnover  (1-3). 
Virtually all  lymphoid cells in  the organ can  be labeled after 3-4 d  of exposure to 
tritiated thymidine. It is striking, therefore, that the small cells forming the dominant 
population are themselves inactive in DNA synthesis. Proliferation takes place only in 
a  minority class of large and  medium-sized lymphoblasts, which  traverse a  full cell 
cycle in  as little  as 8  h  and  give rise to the small,  postmitotic cells by asymmetric 
division (4-6). It has been estimated that the period of rapid division lasts only 1-1.5 
d,  after which  the  accumulated  small cells remain  in  the  thymus  for 3-4  d  before 
death or export (5, 6). 
The lymphoblasts thus represent the immediate precursors of most other thymocytes 
and, very likely, the ultimate precursors of T  cells in the periphery. Although a great 
deal  has been learned  in recent years about the signals that  trigger proliferation  in 
mature,  functional  T  cells  (7-10),  those  that  drive  the  intense  mitotic  activity  of 
thymic lymphoblasts are completely obscure.  It is not known,  for example, whether 
any part of the thymoeyte antigen receptor must be engaged. For mature lymphocytes, 
the  linkage  between  antigen  recognition  and  mitogenesis  is  a  central  feature  of 
immune specificity, and, to the extent that they have been stimulated successfully in 
vitro, small thymocytes also seem to require contact with antigen or a corresponding 
lectin  (11-13).  If, in contrast, proliferation signals for thymic blast cells bypass their 
antigen  receptors, then the processes converting these blasts into small lymphocytes 
take  on  profound  functional  significance.  On  the  other  hand,  if interaction  with 
stromal  histocompatibility antigens  turns  out  to be required,  it may be possible to 
formulate  mechanisms  in  precise  terms  to  explain  the  apparent  influence  of the 
thymic stroma on the antigens that T  cells later recognize as "self" (14,  15). 
Before the triggering requirements of thymic blast cells can be compared with those 
of small thymocytes and peripheral T  cells, the blasts must be identifiable by some 
characteristics other  than  size and  mitotic activity. The studies  reported  here were 
designed to search  for patterns of gene expression that  distinguish  the proliferating 
cells in the thymus from the majority populations in both cortex and medulla. To this 
end,  populations  highly enriched  in  cycling cells  have been  isolated  by centrifugal 
elutriation  and characterized  by biosynthetic  labeling.  This has  permitted  a  direct 
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comparison between the products of the small, peanut agglutinin-binding  cells of the 
thymic cortex and those of their rapidly dividing precursors. The results show a clear 
and unexpected difference between them in de novo synthesis of the surface glycopro- 
tein, thymus-leukemia antigen (TL). 1 
Materials and Methods 
Animals.  C57BL/6-Tla a (B6-TL+),  C57BL/6 (B6), and A/J mice were bred in the animal 
facility at The Salk Intitute. Age- and sex-matched animals  were used in individual  experiments, 
usually between 4 and 6 wk of age. 
Antisera.  Lyt-2,  Lyt-3  glycoprotein complex  (Lyt-2/3)  was  detected  with  a  monoclonal 
antibody specific for the Lyt-2.2 allele (aLyt-2) (16). This was generously provided by Ulrich 
Hammerling (Memorial Sloan-Kettering Cancer Center, New York),  as was the monoclonal 
antibody 18/20 (17) against the TL.3 determinant. The latter monoclonal  was used for immune 
precipitation of TL because it was free of reactivity with Qa-1 (18). For fluorescent staining of 
surface TL  + cells,  a  different monoclonal TL antibody (10-79.4)  was  used. This was  kindly 
donated by Michael Chorney and Fung-Win Shen (Memorial Sloan-Kettering  Cancer Center) 
as a  high-titer ascites,  and showed  the same specificity in immune precipitation as  18/20 (E. 
Rothenberg and M.  Chorney, unpublished observations). Fluorescein-isothiocyanate-conju- 
gated  goat  anti-mouse IgG was  obtained through  the  Research  Resources program  of the 
Division of Cancer Cause and Prevention, Biological Carcinogenesis Branch of the National 
Cancer Institute, Bethesda, Md., courtesy of Dr. John Cole. 
Cell Fractionation  by Centrifugal Elutriation.  Single-cell  suspensions  ofthymocytes were prepared 
as described previously (19-21) or by pressing thymus fragments gently through a  200-mesh 
stainless steel screen. The suspension medium was HEPES-buffered Dulbecco's modified Eagle's 
medium (DME) with 5% heat-inactivated fetal bovine serum (FCS; Hy-Clone, Sterile Systems, 
Inc., Logan, Utah). The cells were washed and resuspended at up to 10  s cells/ml in the same 
medium or in Ca  2+- and Mg2+-free Hanks' balanced salt solution supplemented with 5 mM Na 
azide and 2.5 mg/ml of bovine serum albumin (BSS/BSA). A sample of 5 ml (up to 5 ×  108 
ceils) was loaded into a spinningJE-6  elutriator rotor (Beckman Instruments, Inc., Spinco Div., 
Palo Alto, Calif.) at 18-22°C and elutriated with a continuous flow of BSS/BSA. The flow rate 
was controlled by a Cole-Parmer Masterflex pump equipped with a ten-turn Helipot poten- 
tiometer  (Beckman Instruments, Inc.). The  first  150-200 ml was  collected as  flowthrough; 
subsequently, small, medium, and large cell fractions of the same volume were harvested by 
sequential increases in the pump speed. The elutriated cells were collected in centrifuge bottles 
with 1.5 ml FCS and kept on ice thereafter. 
Various settings of rotor and pump speeds  were  used  throughout  this study. For many 
experiments, a rotor speed of 1,950 rpm was used. In this case, flowthrough cells were collected 
at ~8 ml/min, the small-cell peak fraction at  11.5 ml/min, medium cells at  15 ml/min, and 
large cells at 21-23 ml/min. An equivalent but more rapid fractionation was achieved with the 
rotor speed set at 2,850 rpm, loading the sample at  16.5 ml/min, and collecting small cells at 
21.5 ml/min, medium cells at 28 ml/min, and large cells at 37-45 ml/min. Settings were chosen 
to separate most of the small cells from the less viable cells in the flowthrough; thus, all fractions 
except the flowthrough were >95% viable. The flowthrough was also occasionally contaminated 
with unfractionated cells if back pressure developed in the rotor during sample loading. Overall 
recovery of cells depended on the viability of the initial cell suspension but frequently exceeded 
90%. In the worst cases, small thymocytes contaminated the medium cell fraction to an extent 
of 50% and the large cell fraction to 20-30%. 
After fractionation, the cells were recovered by centrifugation at 2,000 rpm for  10 min at 
4°C. They were washed once in isotonic buffered saline solution without azide before incubation 
1  Abbrevtations used in thzspaper." BSS/BSA, Hanks' balanced salt solution without Ca  z÷ or Mg  z÷, containing 
5 mM  Na azide and 2.5  mg bovine serum albumin  per  milliliter; C, haploid  DNA content;  DME, 
Dulbecco's modified Eagle's medium; FCS, heat-inactivated fetal bovine serum; Lyt-2/3, Lyt-2, Lyt-3 
glycoprotein complex as detected by otLyt-2; PBS, Dulbecco's phosphate-buffered saline (with Ca  2+ and 
Mg  ~+  unless stated);  PBS/I%,  Dulbecco's PBS  with  1%  (vol/vol) fetal bovine serum; PNA, peanut 
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with  [aSS]methionine.  In control experiments, exposure of thymocytes to  azide followed  by 
washing had no effect  on the subsequent synthesis of any of the gene products studied here, 
whether monitored immediately or after an additional 18 h in tissue culture (data not shown). 
Fractionation Based on Peanut Agglutinin  (PNA) Binding.  Cells were fractionated by a modifi- 
cation of the "panning" technique described by Wysocki and Sato (22). Petri dishes (no.  1005, 
Falcon Labware, Becton, Dickinson & Co., Oxnard, Calif.)  were coated at room temperature 
with 4 ml of a 20 pg/ml solution of PNA (Vector Laboratories, Inc., Burlingame, Calif.) in 0.15 
M NaCI, 0.05 M Tris-HCl, pH 9.5. The concentration of 20-25/~g/ml was chosen to bind the 
maximum percentage of cells without blocking or redistributing the PNA receptors as subse- 
quently assayed by staining with fluorescein-conjugated PNA. After  1-2 h  excess PNA was 
removed, and the plates were washed twice with Dulbecco's phosphate-buffered saline (PBS) 
and once with chilled PBS supplemented with  1% FCS  (PBS/I%).  Suspensions of no more 
than 3.5 ×  107 cells in PBS with 5% FCS and 1 mM Na azide were gently applied to the plates 
(10  T eells/ml) and incubated at 4°C for 75-90 min. Unbound PNA- cells were then collected 
with two washes of PBS/I%. The adherent PNA  ÷ cells were eluted by incubating  the plates for 
5-10  rain at  room  temperature with  4-5  ml  of 0.2  M  D-galactose  in PBS/I%;  they were 
harvested by thoroughly flushing the plates with a  pasteur pipette. The plates were washed 
once or twice more with galactose-containing medium to complete the elution. Before further 
processing,  the PNA- cells were also exposed  to galactose to remove any trace of surface-bound 
PNA. Overall recovery from this procedure was  consistently ~70%;  it was not improved by 
reducing the time that the cells were allowed to adhere to the plates. 
Determination of DNA Content.  Cells were fixed in 70% ethanol and stained with mithrarnycin 
(23) using the method described by Hyman and Stallings (24). Mithramycin was generously 
donated by Pfizer, Inc. (New York). The cells were then analyzed by flow microfluorometry in 
a  Los Alamos-type fluorescence-activated cell sorter,  using an excitation wavelength of 457.9 
nm. Data were recorded as linear fluorescence intensity histograms from a  1024-channel pulse 
height analyzer (Fig.  1, left  panels) or from a  256 ×  256-channel dual parameter display of 
fluorescence vs. light scatter (Fig. 1, right panels). The fraction of cells in G0/G1 was calculated 
from the number of cells in the left-hand half of the 2C DNA content peak, divided by the 
overall number of cells in the distribution (objects with ~6C DNA content excluded). 
Fluorescent Staining6o  f  Surface  TL.  Cells  were  pelleted  in  3-ml  glass  conical  tubes  and 
resuspended (4  ×  10  cells in 40 #1)  in BSS/BSA or a  1:10 dilution of monoclonal anti-TL 
antibody in BSS/BSA. They were incubated for 20 min on ice, diluted with 1 ml of BSS/BSA, 
and centrifuged through a 0.4-ml cushion of FCS. The pellets were then resuspended in 40/zl 
of fluorescein-conjugated  goat anti-mouse IgG, diluted 1:20 in BSS/BSA. After 30 min on ice, 
the cells were diluted and centrifuged as before and finally resuspended in Ca  2+- and Mg2+-free 
PBS with  1% (vol/vol) formaldehyde. Before analysis on the cell sorter,  the suspensions were 
filtered through nylon mesh (Nytex; TETKO, Inc., Elmsford, N. Y.). 
For flow  microfluorometry, an excitation wavelength of 488  nm was  used, and the cell 
distribution histogram was displayed on a 256 ×  256-channel dual-parameter matrix plotting 
the  logarithm  of fluorescence  intensity vs.  forward  angle  light  scatter  (linear scale).  The 
logarithmic amplifier was set to give a  three-decade full scale  in the fluorescence dimension. 
Fractions of TL-positive cells (log fluorescence channels 72-256) were calculated for populations 
gated according to light scatter to exclude dead cells (in light scatter channels 1-40). The small 
cells in this analysis (light scatter channels 40-140) included 84% of the total viable cells, and 
the large cells (channels 141-256)  correspondingly included 16% of the total. Genetically TL- 
negative thymocytes stained  similarly to  the  B6-TL  +  thymocytes exposed  to  second-stage 
reagent alone (Fig. 2 B). 
Cytotoxic Elimination with Anti-TL.3 Antibody.  Individual thymocyte samples were suspended 
at 2 ×  107 cells/ml in a  1:200 dilution of monoclonal anti-TL.3 (18/20)  in HEPES-buffered 
DME, or in HEPES-buffered DME alone. After incubation for 30 min on ice, the cells were 
diluted  with  5  ml  of HEPES-buffered  DME  that  contained 2.5  mg/ml  of bovine serum 
albumin, then centrifuged and resuspended at the original cell concentration in rabbit comple- 
ment. A pretitered batch of rabbit complement, kindly provided by Robert Hyman of The 
Salk Institute, was  used at a  final dilution of 1:9 in HEPES-buffered DME. The cells were 
incubated 45 min at 37¢'C with intermittent agitation. They were then diluted and washed as ELLEN  ROTHENBERG  143 
before and finally resuspended in [~S]methionine-containing  medium for biosynthetic labeling, 
as described below. After 30 rain at 37°C, the cells were lysed and incorporation was determined 
by precipitation of aliquots of lysate with trichloroacetic acid. 
Metabolic Labeling of Cells.  Cells were biosynthetically labeled with [sns]methionine (Amer- 
sham Corp., Arlington Heights, Ill.) in methionine-deficient DME medium with 2% dialyzed 
FCS, 2 mM L-glutamine, and 50 #M 2-mercaptoethanol. Incubations were for 30-50 min at 
37°C in a humidified atmosphere of 10-13% CO~. Concentrations of isotope were typically 500 
#Ci/ml to prepare lysates for immune precipitation or 135 #Ci/ml for analytical purposes (e.g., 
Table III).  The  incorporation of label  by the  large  lymphoblasts was  reduced  as much  as 
threefold  in  incubations at  >3  ×  107  cells/ml,  although  the  small  lymphoeytes  seemed 
unaffected by high cell density. Consequently, labeling of thymocytes before elutriation tended 
to underestimate the differences between large and small thymocytes in methionine uptake 
(Table I, experiment 2)  unless the incubation was carried out in larger volumes than those 
routinely used here. Labeling was terminated as described previously (19). 
Immune Precipitation and Gel Electrophoresis.  These conditions were as described previously (19, 
20). To resolve intracellular TL from background aetin, the concentration of sodium dodecyl 
sulfate (Bio-Rad Laboratories, Richmond, Calif.) in the running buffer was raised to 0.2%, as 
discussed previously (25). The gels were processed for fluorography (26) and exposed for 7 d at 
-70°C. 
Results 
Enrichment of  Blast Cells by Elutriation.  The experiments described here were designed 
to compare small cortical thymocytes with presumptive cortical blast cells in their 
synthesis of specialized, tissue-specific gene products. Because protein synthesis cannot 
be analyzed in individual cells, it was necessary to separate the dividing precursor 
cells physically from the postmitotic cells. Fractionation by size has been reported to 
give excellent resolution between these populations when unit gravity sedimentation 
was used (2, 27). For this study, to reduce fractionation time and preserve biosynthetic 
activity, large and small cells were separated instead by centrifugal elutriation (28, 
29).  Typical distributions of B6-TL  + thymoeytes after a  single round of elutriation 
are shown in Table I. Similar results were obtained with thymocytes from B6 mice. 
To  assay  for  enrichment  of cells  in  different  growth  states,  the  DNA-binding 
fluorescent dye mithramycin was used to stain elutriated thymocytes. DNA content 
per cell was then estimated by flow microfluorometry, as shown in Fig.  1. Typically, 
at least  75-85% of unfractionated thymocytes were in G0/G1 (Fig.  1, top panels) as 
judged by their 2C (diploid) DNA content, with the remainder in S (2C-4C), G2 + 
TASLE  I 
Fractionation of Thymocytes by Elutriation 
Cell sample 
Experiment 1  Experiment 2  Experiment 3 
Fraction of  cpm/  Fraction  epm/  Fraction of  PNA  +  PNA- 
cells  cell*  of cells  cell  cells  cpm/cell  epm/eell 
Total  --  1.1 
Flowthrough  36%  0.32 
Small  58%  0.70 
Medium  6%  3.1 
Large  0.6%  6.7 
Labeled before or after  After 
elutriation: 
Age of mice  4 wk 
--  0.83  --  1.46 
18%  0.59  16%  0.33  0.18 
65%  0.62  73%  0.22  0.38 
15%  1.5  8.5%  1.2  1.6 
2%  3.9  2.5%  5.7  5.8 
Before  After 
5 wk  6 wk 
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Fro.  1.  DNA content ofelutriated  thymocytes. Left- and right-hand panels show results from two 
independent experiments. Unfractionated cells, cells from the peak small-cell fraction, and cells 
from the largest cell fraction were stained with mithramycin and analyzed by flow microfluorometry. 
Mithramycin fluorescence  intensity is proportional to DNA content. 2C denotes the DNA content 
of cells in Go or G1 phase; 4C is the DNA content of cells after one full round of DNA replication 
(G2 + M phase). In the experiment shown in the right-hand panels, the DNA content histogram is 
displayed with a third dimension recording the forward angle light scatter, a measure of the size of 
the fluorescent  objects. In the unfractionated and small cells, a significant proportion of the objects 
with 4C DNA content scatter distinctly more light than the majority of the cells (arrow in middle 
right panel). These are probably doublets of cells that have only 2C DNA content individually. 
M  (4C), or G0/G1 doublets ("4C" DNA content). Elutriated "small" thymocytes were 
relatively  depleted  in  S  and  G2  +  M  cells  (Fig.  1,  middle  panels).  In  contrast, 
elutriated "large" thymocytes were highly enriched for actively cycling cells (Fig.  1, 
bottom panels). Here, <40% of the cells were in G0/G1, with 35-50% in G2 +  M, and 
the remainder in S phase. The medium fraction also included elevated percentages of 
cells with partially or completely replicated DNA  (data not shown). Since the most 
primitive thymocytes apparently traverse a  full cell cycle in 6-10 h  (4-6), they are 
likely to be concentrated in the medium- and large-cell fractions. 
Large and small elutriated thymocytes also showed  dramatic differences in their 
rates  of  [aSS]methionine  incorporation  in  vitro  (Table  I).  The  amount  of  label 
incorporated per cell in a 30-50-min incubation was routinely 5-20-fold higher in the 
large cells than in the cells from the peak small cell fraction, although the viabilities 
were equally high. This difference was not an artifact of stress during the fractionation 
procedure,  for it was seen whether the cells were labeled before or after elutriation ELLEN  ROTHENBERG  145 
(Table I, compare experiments 1 and 2). The large cells thus represent the enrichment 
of a  thymocyte population  that  is  highly  atypical  with  respect  to  overall  protein 
synthesis as well as with respect to DNA synthesis. 
The extent  of this  enrichment  by elutriation  alone depended upon  the age and 
strain  of the  mice.  In  B6  and  B6-TL  +  mice  >7  wk  old,  a  simple  decrease in  the 
lymphoblast population could be inferred from both a  reduced yield of cells in the 
large  fraction and  a  lower level of [~S]methionine  incorporated  per  large  cell.  In 
A/J mice, on the other hand, the number of cells recoverable in the large fraction was 
dramatically increased to >15% of the total; however, these also incorporated <1/3 
as much label per cell as the large B6 thymocytes (data not shown). Similar results 
were obtained with animals  from 2.5 to 6.5 wk of age. The difference in thymocyte 
fractionation patterns may be related to the known differences between A/J and B6- 
background mice in various aspects of thymus physiology (30). 
Enrichment of Cortical Thymocytes by PNA Binding.  There is some evidence that most 
cortical and medullary thymocytes develop from separate pools of dividing precursor 
cells  (31-34).  To relate phenotypic differences between cells to  maturation,  it  was 
important to be able to compare small thymocytes with lymphoblasts within the same 
lineage. Therefore, cortical and  medullary thymocytes were fractionated physically 
on  the  basis  of their binding  by the  lectin  PNA  (35,  36).  PNA  binds  to  ~90%  of 
thymocytes (PNA+),  and  these  display characteristic markers  of cortical cells.  The 
unbound  cells,  in  surface  phenotype,  functional  competence,  and  in  vivo steroid 
resistance, correspond closely to medullary cells and peripheral T  cells (36-41). The 
first cells repopulating the thymus after irradiation  include both PNA  + and PNA- 
cells  (42), so it  is likely that  the distinction is present in  the most primitive cells of 
each lineage. To isolate cortical lymphoblasts for comparison with their postmitotic 
descendants, the size fractionation and PNA fractionation were combined. 
Primitive lymphoblasts were first separated from small resting cells by elutriation; 
then small, medium, and large cells were fractionated by binding to PNA-coated petri 
Fro,  2.  Surface expression of TL on B6-TL* thymocytes. Thymocytes were stained with  mono- 
clonal antibody against TL (10-79.4) and fluoresceinated goat anti-mouse IgG. They were analyzed 
for forward-angle light scatter and fluorescence intensity on a flow microfluorometer equipped with 
a  log amplifier for fluorescence detection. The full scale (channels 1-256)  of log fluorescence covers 
three decades. Light scatter was detected with linear amplification.  (A)  Thymocytes stained with 
anti-TL. The dual-parameter display shows the analysis of 35,000 events. Light scatter channels 
1-40 contained dead cells or debris. White outlines indicate the boundaries of the distributions of 
small  cells  (scatter  channels  41-140)  and  large  cells  (scatter  channels  141-2.56)  with  positive 
fluorescence (fluorescence channels 72-256). The percentages of positive cells are given in the text. 
(B) Control staining with second stage alone. Using the same scale and gain settings as in A, 5.5% 
of the cells were positive. 146  BIOSYNTHETIC  PHENOTYPE  OF  THYMIC  LYMPHOBLASTS ELLEN  ROTHENBERG  147 
TABLE II 
Relative Levels of TL Synthesis in Different Populations of Thymocytes 
A  B 
TL synthesis per 2 ×  106  TL labeled per cell:~  cpm* 
Ratio between cell samples 
Experiment  Experiment  Experiment  Experiment 
1  2  1  2 
Unfractionated/un fractionated 
Small PNA÷/unfractionated 
Medium PNA*/un fractionated 
Large PNA÷/unfractionated 
(1 .~  (1.~  (1.0)  (1.0) 
0.26  0.34  0.05  0.05 
1.9  1.4  1.5  1.2 
2.3  1.8  11.2  7.0 
Small, medium PNA-/unfractionated  <0.03  <0.03  <0.01  <0.01 
Large PNA-/unfractionated  0.39  0.19  1.9  0.75 
Large PNA÷/small PNA  +  8.8  5.2  209  135 
*  Anti-TL immune precipitates were prepared  from inputs  of 2  X  10  s cpm of [~S]methionine-labeled 
protein  and  analyzed  by sodium  dodecyl sulfate gel  electrophoresis  and  fluorography.  Radioactivity 
incorporated into the TL band was quantitated by scanning the fluorograms  with a Zeineh microdensi- 
tometer  (LKB  Instruments,  Inc.,  Rockville,  Md.)  and  integrating the areas  under  the peaks  with a 
planimeter (Hewlett-Packard Co., Palo Alto, Calif.). The value shown is the ratio between these areas in 
the two samples specified. 
The value in A was converted to the ratio of the amounts of newly labeled TL per cell by multiplying it 
by the ratio of counts per minute incorporated per cell in the two samples. This calculation compares the 
different  amounts of TL synthesized  per cell, if the specific activities of the methionine pools are the same 
in the two populations of cells. 
dishes  ("panning";  22).  In  B6-TL  ÷  thymocytes,  PNA +  cells  formed  the  majority  of 
each size fraction,  comprising up  to 90% of the small cells, 85% of the medium  cells, 
and  80%  of the  largest  cells.  The  PNA-  fraction  of the  large  cells  was  at  least  as 
enriched  as  the  PNA ÷  fraction  in  cells  with  >2C  DNA  content  (data  not  shown), 
however,  in agreement  with other evidence for a  PNA-  lymphoblast  population  (37, 
42).  As shown in Table I, experiment  3, the rate of [~S]methionine incorporation per 
cell was similar for PNA ÷ and  PNA-  cells in any one size fraction. Therefore, in both 
classes of cells, any developmental transition  from large to small must be accompanied 
by a  sharp  decline in methionine uptake  and/or  protein synthesis per cell. 
Distinctions  between  the  six  pools  of  thymocytes  yielded  by  this  fractionation 
scheme  could  be revealed by  analysis  of their patterns  of ongoing protein  synthesis, 
using  immune  precipitation  from  metabolically  labeled  cell  lysates.  To  compare 
different  samples,  the  radioactive  inputs  were  normalized  to  total  [~S]methionine 
Fro.  3.  Synthesis  of Lyt-2/3 and TL in fractionated thymocytes.  Cells were elutriated into small, 
medium,  and  large  size  classes. They  were  then  incubated  with  [aSS]methionine,  washed,  and 
separated  into PNA  + and  PNA- fractions.  Labeling was  for 45 min, and the amounts of isotope 
incorporated per cell are given in Table I  (experiment 3). For lanes  1-7,  1 ×  l0  s cpm of labeled 
protein were analyzed by immune precipitation with anti-Lyt-2.2  monoclonal antibody. None of 
the three bands  indicated as Lyt-2/3 could be precipitated  from lysates  of congenic thymocytes 
bearing the alternative Lyt-2 allele (B6-Lyt-2.1:3. l). For lanes 9-14, 2 X 10  s cpm of labeled protein 
from  the  indicated  lysates  were subjected  to immune precipitation  with  anti-TL.3  monoclonal 
antibody. Lysates from small PNA- thymocytes (not shown) contained at least twofold less labeled 
TL than those from small PNA  + ceils. Lane 8 was a normal mouse serum precipitate from 2 X 106 
cpm  of the  unfractionated  thymocyte lysate  (N).  Tot,  unfractionated  thymocytes;  Sm,  "small" 
fraction; Med, "medium" fraction; Lg, "large" fraction; PNA-, unbound  by PNA-coated plates; 
PNA  +, bound to and eluted from PNA-coated plates. 148  BIOSYNTHETIC PHENOTYPE OF THYMIC  LYMPHOBLASTS 
incorporation rather than to cell number. Thus, de novo synthesis of each product was 
measured as a  fraction of the overall protein synthesis in a  cell population.  This in 
effect corrected  for differences in cell  volume, and  for the replacement of large-cell 
components otherwise diluted by rapid division. 
Restriction  of TL Synthesis  to Blast Cells.  The TL glycoprotein (19,  43)  is known to 
be expressed on the surfaces of 70-80% of all thymocytes in B6-TL  + mice, specifically 
marking  the  cortical  cells  (43-45).  When  thymocytes  were  analyzed  by  indirect 
immunofluorescence with monoclonal antibody to TL (Fig. 2), ~80% of the cells were 
positive, with good distinction between TL  + and TL- cells. Most of the positive cells 
were small, as defined by light scatter (Fig.  2).  The percentages scored as TL  + were 
78% in the small size class and 82% in the large class, although the latter stained more 
heterogeneously than the small TL  + cells. 
When fractionated thymocytes were assayed for ongoing TL synthesis, however, a 
very different  result  emerged.  Compared with  unfractionated  cells,  synthesis of the 
TL glycoprotein was enhanced  in  PNA  + medium and large thymocytes (Fig.  3, cf. 
lanes 9,  12, and  14; Table II). On the other hand, in small thymocytes TL synthesis 
was sharply reduced,  even in  relation  to their low overall protein synthesis  (Fig.  3, 
lane  10; Table II). The contrast was more dramatic when considered in terms of TL 
synthesis  per cell,  since corresponding amounts of radiolabel  were incorporated  by 
>10 times as many small cells as large cells. In other experiments, the same pattern 
of  TL  synthesis  was  observed  whether  labeling  was  carried  out  before  or  after 
elutriation  (data  not  shown),  ruling  out  selective damage to the small cells during 
centrifugation.  These results  indicate  that  the  majority of thymocytes that  express 
surface TL are not actively engaged in the synthesis of this glycoprotein to a significant 
extent. The TL on their surfaces must therefore be a  relic of prior synthesis in their 
lymphoblast precursors. 
Selective  Regulation  of  TL  Synthesis.  Biosynthetic  labeling  cannot  indicate  what 
fraction  of the  cells  in  a  heterogeneous  population  makes a  particular  product,  or 
indeed what fraction contributes to ongoing protein synthesis at all. The low activity 
of small cells in making TL could be due either to selective regulation of TL synthesis 
during the transition  to the resting state or to elimination of surface TL  + cells from 
the metabolically active pool. The question is not trivial because of the high rate of 
death, in vivo and in vitro, among small cortical thymocytes (27, 31, 46, 47). Thus it 
was important  to establish whether cells expressing surface TL were responsible for 
any of the protein synthesis in the small-cell fraction. 
To  assay the  level  of overall  protein  synthesis  in  cells  bearing surface  TL,  size- 
fractionated thymocytes were treated with monoclonal anti-TL antibody and com- 
plement,  or  with  complement  alone,  and  then  labeled  with  [35S]methionine.  The 
resulting levels of methionine incorporation per input cell are summarized in Table 
III. Cytotoxic elimination  of surface TL  + cells reduced  protein  synthesis in  unfrac- 
tionated  thymocytes by 66%;  a  similar fraction of synthesis was also  vulnerable  to 
elimination  in  both  large  and  small  thymocyte populations.  The  elimination  was 
specific for expression  of surface  TL,  because  incorporation  was  not  reduced  with 
respect to the complement control when the thymocytes were obtained from congenic, 
TL- B6/J mice (data not shown). Therefore, cells bearing TL were still responsible 
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TABLE III 
Biosynthetic Activity in Thymocytes Bearing Surface TL 
Fraction of  Fraction 
Sample  cells  C'* alone  aTL +  C'  TL+:]: 
cpm/input  cell  cpm/input  cell 
Unfractionated  --  0.024  0.008  66% 
Small  82%  0.019  0.006  67% 
Medium  7.3%  0.088  0.043  51% 
Large  0.8%  0.27  0.09  67% 
* Complement. 
:~ Percent  reduction  in  protein  synthesis after specific cytotoxic elimination, 
calculated from values given. 
This means  that  the cessation of de novo TL synthesis  must  represent  a  regulatory 
event affecting the expression of this gene product specifically. 
Maintenance  of Lyt-2/3 Synthesis  by Small Cortical Thymocytes.  An example of a tissue- 
specific gene product that continued to be made in postmitotic thymocytes was Lyt- 
2/3.  The  Lyt-2/3  antigen  marks  the  surfaces  of certain  functional  subclasses  of 
peripheral T  cells (48-51) and virtually all cortical or PNA + thymocytes (32, 40-42). 
In the thymus, therefore, there is extensive overlap between the cells expressing surface 
Lyt-2/3  and  those expressing surface TL  (52,  53).  Unlike  TL,  however, the  three 
glycoprotein chains of the Lyt-2/3 complex ("Lyt-2"; 54, 55) were strongly labeled in 
PNA  ÷ cells of all size classes (Fig. 3, lanes 3, 5, and 7). In agreement with their steady- 
state pattern of membrane expression (40, 41), synthesis of these molecules was low or 
undetectable  in  the  corresponding  PNA-  populations  (Fig.  3,  lanes  2,  4,  and  6). 
Therefore the ongoing production of Lyt-2/3 by small cells was not due to rare Lyt- 
2/3  + medullary thymocytes, it could be firmly attributed to the cortical population 
that was so poor in TL synthesis. 
Discussion 
In  the work presented here, a  rapid  and  gentle cell fractionation procedure has 
been  used  to  study  the  primitive,  dividing  lymphoblasts  in  thymus  glands  from 
normal  B6-TL  ÷ mice. This protocol is  not  claimed to yield homogeneous pools of 
cells.  What it does, instead, is to enrich physiologically important minor populations 
to the point where features of their phenotypes can be discerned. Although a  given 
pool of cells may not be pure, characteristics unique to it can be identified by the way 
they partition among the cell fractions. This is a  vital point for assigning character- 
istics,  such  as  immune  responsiveness or biosynthesis of specific products, that  are 
difficult  to  assay  at  a  single-cell  level.  In  the  case  of dividing  lymphoblasts,  it  is 
impossible  to  conclude  what  percentage  of the  cell  population  is  synthesizing  a 
particular marker;  however, if a  marker  that  is  made  at  an  enhanced  rate  in  the 
lymphoblast fraction is made poorly in the small-cell fraction, then the high rate of 
synthesis cannot be attributed to contamination by the small cells. 
A  result  of this  analysis  has  been  the  identification  of a  minor  population  of 
thymocytes that appears to be responsible for most of the organ's active synthesis of 
TL glycoprotein. Although most of the cells in the thymus, especially small cortical 
cells, exhibit surface TL, de novo synthesis of this molecule is virtually confined to cell 
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most active, though the data in Fig. 3 and Table I! do not rule out some TL synthesis 
by  the  largest  PNA-  cells.  A  considerable  body of literature  indicates  that  small 
cortical thymocytes are all postmitotic descendants of large- and medium-sized cells 
(4-6,  27).  The  present  results  confirm  the  precursor-product  relationship  between 
those large cells that actively make TL and the surface TL-positive majority popula- 
tion of thymocytes. The continued display of TL by the latter cells may simply reflect 
their lack of membrane turnover. 
The interest of this finding lies in its specificity. In spite of a generalized reduction 
in [3~S]methionine incorporation per cell, small thymocytes do not shut off production 
of other surface glycoproteins to nearly the same extent as TL. Synthesis of Lyt-2/3 
accounts for at least as high a  fraction of total protein synthesis in small PNA  + cells 
as in large ones. This contrasts sharply with the considerable reduction in TL synthesis 
even in relation to the diminished overall incorporation of label by these cells. Because 
virtually all small PNA  + cells display both Lyt-2/3 and TL on their surfaces (52, 53), 
it is likely that  cells continuing to make Lyt-2/3 but  not  making TL were derived 
from precursors that  actively produced both.  Moreover, the difference between the 
ways TL and Lyt-2/3 are regulated does not simply reflect the difference between a 
marker  of strictly  intrathymic  cells  and  a  marker  of mature,  peripheral  T  cells. 
Synthesis of another product specific for cortical thymocytes, terminal deoxynucleo- 
tidyl transferase  (18,  20,  56-58),  is maintained  in  the small  cells like Lyt-2/3, not 
aborted like TL (data not shown). Consistent with this behavior in vivo, TL synthesis 
shuts off when unfractionated thymocytes are incubated in short-term tissue culture, 
whereas synthesis of terminal transferase, H-2, and Lyt-2/3 continues (D. Triglia and 
E. Rothenberg, unpublished observations) (18,  21). This means that de novo synthesis 
of TL is not a common feature of all metabolically healthy cortical cells, but rather 
a property specific to the large cortical lymphoblasts. 
In the medium and large cell etutriator fractions, the enhancement of TL synthesis 
increases monotonically with the increased proportion of cycling cells. It seems highly 
probable,  then,  that  TL is  only made  by thymocytes during  their early period of 
rapid proliferation. This could mean either that TL synthesis is cell cycle dependent 
or that TL synthesis marks a unique stage in the thymic developmental progression. 
To  test  these  possibilities  critically, postmitotic  ceils  of a  rigorously purified  TL  + 
lineage  must  be  restimulated  to  cycle  and  assayed  for  renewed  synthesis  of the 
glycoprotein. In preliminary studies, enriched PNA  + populations have shown no signs 
of increased TL production with mitogenesis (E. Rothenberg and D. Triglia, unpub- 
lished observations). If confirmed, this would indicate that TL synthesis is not linked 
to proliferation generally but to a unique phase of proliferation. TL shutoff, in other 
words, appears to be irreversible. 
The central purpose of this investigation has been to identify patterns of biosynthesis 
that  distinguish  the  stem  cell-like  thymic  lymphoblasts  from  their  cortical  and 
medullary descendants.  Maintenance of these patterns could then be monitored in 
thymocytes responding to experimental manipulation, to indicate any change in their 
developmental state.  The results presented here indicate that  Lyt-2/3 and TL may 
represent valuable parts of such a pattern. In cells derived from the thymic cortex, the 
maintenance  of Lyt-2/3  synthesis--possibly  extending  into  functional  maturity-- 
allows this product to be used as a rough index of cell viability. Conversely, because 
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expression, it may prove to be an exceptionally sensitive indicator of developmental 
transitions.  If TL  synthesis  were  not  actively  restored,  then  stimulation  of small 
cortical  thymocytes would necessarily give rise to TL- progeny cells.  No additional 
"maturation"  events  need  occur  (11,  59,  60);  the  TL  initially  present  on  the  cell 
membranes would simply be diluted out. On the other hand, stimulation of thymo- 
cytes in such a way as to maintain TL synthesis, as in TL  ÷ lymphomas, could indicate 
that some blast cell population was also being maintained  in a  distinct  "primitive" 
state.  TL synthesis may thus  provide an assay for the unique  proliferation  require- 
ments of an elusive but important population of early lymphoid cells. 
Summary 
Large cortical  thymocytes from C57BL/6-Tla a mice have been  prepared rapidly 
and in high yield by a combination of centrifugal elutriation and differential binding 
to peanut agglutinin  (PNA)-coated plates.  The cells in these lymphoblast-rich frac- 
tions were clearly distinct  from the majority of thymocytes, with up to 70% in the S 
or G2 +  M phases of the cell cycle and an average rate of [SSS]methionine incorporation 
per cell up to 20 times higher than that of the majority population. 
The  populations  of  cells  resolved  in  this  fractionation  were  characterized  by 
monitoring their rates of synthesis of specific glycoproteins, thymus-leukemia antigen 
(TL) and the Lyt-2, Lyt-3 complex (Lyt-2/3), relative to their total protein synthesis. 
Cells  that  bound  to  PNA  synthesized  high  levels of Lyt-2/3,  consistent  with  their 
identification as cortical thymocytes. Those that failed to bind made little or no Lyt- 
2/3, as expected for medullary cells, The fraction of dividing lymphoblasts that bound 
to PNA was enriched  in cortical  thymocyte precursors, including  all the large cells 
detectably  active  in  synthesizing  Lyt-2.  It  differed  sharply  from the  small  cortical 
cells, however, in the synthesis of TL. Although both populations displayed abundant 
surface  TL,  the  TL  glycoprotein  was  produced  actively  in  fractions  containing 
dividing cells but made at a  drastically reduced rate by the nondividing majority of 
cortical thymocytes. Thus, TL seems to be made at a narrowly circumscribed stage of 
early thymocyte development that is correlated with rapid proliferation.  In most of 
the descendants of such blast cells, the TL glycoprotein is presumably retained on the 
cell surface as long as no substantial  membrane turnover takes place. Ongoing TL 
synthesis  may therefore serve as a  marker for a  unique  developmental  state which 
terminates rapidly in normal differentiation but may be extended by agents that give 
rise to TL  + thymic lymphomas. 
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